| 7.45 Delayed Data As of Sep 20 |  -0.08 / -1.06%Today’s Change | 6.07 Today|||52-Week Range 25.00 | -51.69% Year-to-Date |
| Previous close | 7.53 |
| Today’s open | 7.57 |
| Day’s range | 7.38 - 7.70 |
| Volume | 17,955,302 |
| Average volume (3 months) | 21,076,024 |
| Market cap | $8.1B |
| Earnings growth (last year) | +85.71% |
| Earnings growth (this year) | -18.82% |
| Earnings growth (next 5 years) | +2.20% |
| Revenue growth (last year) | -16.69% |
| P/E ratio | NM |
| Price/Sales | 0.84 |
| Price/Book | 0.55 |
| Today’s change | Today’s % change | |
|---|---|---|
| BGNEBeigene Ltd | +2.57 | +1.93% |
| BBIOBridgeBio Pharma Inc | +1.74 | +7.09% |
| AKRXAkorn Inc | +0.43 | +11.72% |
| Next reporting date | November 1, 2019 |
| EPS forecast (this quarter) | $0.58 |
| Annual revenue (last year) | $18.8B |
| Annual profit (last year) | -$2.1B |
| Net profit margin | -11.40% |
Sector Health Technology |
Industry Pharmaceuticals: Generic |
President, Chief Executive Officer & Director Kåre Schultz |
Executive Vice President- Global Operations Carlo de Notaristefani |
Corporate headquarters Petach Tikva, Hamerkaz |
